MDS Inc. Files Restated 2007 Quarterly Reports Under US GAAP
01 Febbraio 2008 - 8:52PM
PR Newswire (US)
TORONTO, Feb. 1 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE:
MDZ), a leading provider of products and services to the global
life sciences markets, has filed restated 2007 quarterly reports
under US GAAP, as required by applicable Canadian regulations,
after filing its 2007 annual report and financial statements in US
GAAP for the first time earlier this week. These restated quarterly
reports also correct an error related to the US GAAP valuation of
certain stock-based compensation plans identified during the
year-end audit. The valuation was included in the 'Canadian to US
GAAP' reconciliation to the financial statements in previously
filed 2007 MDS quarterly reports. These stock-based compensation
plans were correctly valued under Canadian GAAP and in MDS' 2007
annual financial statements in US GAAP. The restated quarterly
reports are available in the "For Investors" section of the MDS
website at http://www.mdsinc.com/. To assist investors with
understanding the impact of MDS' conversion from Canadian to US
GAAP, both an "MDS US GAAP Primer", which provides an overview of
the relevant differences between US and Canadian GAAP affecting
MDS, and reconciliation tables for MDS and its business units are
also available on the MDS website at http://www.mdsinc.com/. About
MDS Inc. MDS Inc. is a global life sciences company that provides
market-leading products and services that our customers need for
the development of drugs and the diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
5,500 highly skilled people in 29 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, MDS
Inc., (416) 675-6777 X34721,
Copyright